#InTheNews: HealthPartners has had more than 40K volunteers for their #myGenetics population genomics program, identifying more than 600 with inherited risks for breast, colon, or ovarian cancers. Read about what else they're doing with genetics: bit.ly/4eA7zYJ

#InTheNews: Covering our latest partnership with Recursion is Jonathan D. Grinstein, PhD from Inside Precision Medicine, who speaks to our CCO of Life Sciences, Hylton Kalvaria, about using clinico-genomic datasets to power AI/ML-enabled drug discovery. Learn more: bit.ly/3VWFpQo

#InTheNews: Brian Buntz at Drug Discovery & Development speaks with our CCO of Life Sciences, Hylton Kalvaria, about the "Sequence Once, Query Often" approach to genomic data management. Read more about what's in store for the collaboration with Recursion: bit.ly/4bmy2Gs

#InTheNews: Dr. David Wong, medical director of @MemorialHermann's genoME Program, speaks to Great Day Houston about the importance of early genetic testing for health conditions like breast, ovarian, and colorectal cancers in partnership with Helix. Read: bit.ly/3Y4EA9v

#InTheNews: InvestorPlace highlights our partnership with Recursion in a multi-year agreement, providing large-scale, clinico-genomic data for use in AI models. Read more about how our data helps speed up development for precision drugs: bit.ly/3S99Mkt

#InTheNews: WFMZ-TV 69News speaks to St. Luke's University Health Network' Dr. Christopher Chapman about their four-year "DNA Answers" community health research project with Helix, providing genetic testing for hereditary cancer and heart disease risk. Learn more: bit.ly/3y9mR6e

#InTheNews: @Fox43 speaks to Dr. David Kann of WellSpan Health Health's Gene Health Project, noting that 30,000 people have signed up for Helix-designed genetic tests for hereditary disease and cancer risk. Learn about population-level preventative healthcare: bit.ly/3LpsYq8

#InTheNews: Sanford Health has announced the official launch of their genetic screening study with us, "ImagineYou", which offers no-cost testing for participants to learn of inherited risks for common cancers and heart diseases. Learn more: bit.ly/3Yb8BEH

Today, we're excited to announce our multi-year partnership with The Ohio State University Wexner Medical Center! The Ohio State Genomic Health program will be a 4-year research program aimed at providing greater precision care that will offer no-cost genetic screening to 100,000 Ohioans. bit.ly/3WBiQA3

#InTheNews: Our partners at Mayo Clinic released a study looking into the early results of their Mayo Tapestry population genomics study. Read about the impact of sequencing exomes of more than 44,000 participants, identifying cancer risk in 550, and more: mayocl.in/3W9mFfo

#InTheNews: We have partnered with Sanford Health to announce their genetic screening study "ImagineYou", testing participants for inherited risks of common cancers and heart diseases. Hear from their Chief Physician Dr. Jeremy Cauwels @Keloland: bit.ly/3yaNNmi

#InTheNews: Mayo Clinic released early results of their Mayo Tapestry population genomics study, showing 550 patients identified to carry added risk for disease-causing genetic mutations out of 44,000 sequenced. Read @ASCOpost's story to learn more: bit.ly/4c087V7

#InTheNews: We are working with Sanford Health to launch "ImagineYou", a genetic study screening local participants for inherited risks for disorder such as familial hypercholesterolemia. Learn more about these types of programs from KX News: bit.ly/3ShSxxg

#InTheNews: GenomeWeb names our partnership with Sanford Health, launching a genetic screening study called "ImagineYou", as a top story of the past week. Learn about the impact of screening for lynch syndrome, breast and ovarian cancer syndrome: bit.ly/3y8fI6g

#InTheNews: HealthDay News has covered news from our partners at Mayo Clinic, reporting early results of their Tapestry population genomics study with us. With exomes from more than 44,000 participants sequenced, read more about identifying cancer risk: bit.ly/3We8jKI

#InTheNews: Our Chief Commercial Officer Hylton Kalvaria speaks with Drug Target Review about the benefits of sequencing hundreds of thousands of participants to create datasets that integrate genomic and clinical data for GLP-1s: bit.ly/3WyzaS6

#InTheNews: The Ohio State University Wexner Medical Center will launch the Ohio State Genomic Health program with Helix later in 2024, enrolling 100,000 participants at no cost to screen for variants associated with high cholesterol and various cancers. Read more details from Becker's Hospital Review: bit.ly/4fmcj4N

#InTheNews: KFYR-TV speaks to Linda Wolf of Sanford Health to learn more about our collaborative #ImagineYou population genomics study. Read their report about the benefits to gaining data on local hereditary health conditions: bit.ly/3LLrPJT

#InTheNews: Using our "Sequence Once, Query Often" model, The Ohio State University Wexner Medical Center is launching the Ohio State Genomic Health program over the next four years to run genomic-based tests looking for various cancers and high cholesterol. Read GenomeWeb's report: bit.ly/4d7tkhk

#InTheNews: Times News reports the story of a man from Nazareth, PA, who learned of a genetic health condition after participating in our "DNA Answers" community health research project with St. Luke's Health System. Learn more: bit.ly/4dBj6FQ